20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Establishment Labs Holdings Inc (ESTA) operates in the MEDICAL DEVICES industry and is headquartered in Austin, United States with about 1,004 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, ESTA reported $211M in revenue and ($51M) in net income.
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States.
Interactive charts & full statements → Open the ESTA valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $246M | $211M | $166M | $165M | $162M | $127M | $85M | $90M | $61M | $35M | $20M | $10M |
| Gross Profit | $173M | $146M | $110M | $107M | $107M | $85M | $53M | $55M | $36M | $18M | $10M | $5M |
| Gross Margin % | 70.5% | 69.3% | 66.0% | 64.8% | 65.9% | 67.4% | 62.0% | 61.3% | 59.0% | 51.0% | 51.0% | 51.8% |
| Operating Income (EBIT) | ($19M) | ($39M) | ($50M) | ($65M) | ($40M) | ($25M) | ($28M) | ($31M) | ($24M) | ($20M) | ($16M) | $0M |
| Operating Margin % | -7.6% | -18.5% | -30.1% | -39.4% | -24.5% | -19.8% | -33.0% | -34.5% | -39.0% | -57.6% | -80.0% | -3.8% |
| Net Income | ($39M) | ($51M) | ($85M) | ($79M) | ($75M) | ($41M) | ($38M) | ($38M) | ($21M) | ($35M) | ($22M) | ($2M) |
| Net Margin % | -15.8% | -24.2% | -50.9% | -47.5% | -46.5% | -32.5% | -45.0% | -42.6% | -34.5% | -100.6% | -111.9% | -16.6% |
| EBITDA | ($7M) | ($22M) | ($56M) | ($58M) | ($57M) | ($27M) | ($25M) | ($26M) | ($9M) | ($22M) | ($18M) | — |
| Earnings Per Share (EPS) | $-1.31 | $-1.72 | $-3.00 | $-3.07 | $-3.08 | $-1.72 | $-1.63 | $-1.86 | $-1.22 | $-1.89 | $-1.20 | $-0.27 |
| Shares Outstanding (M) | 30M | 30M | 28M | 26M | 24M | 24M | 23M | 21M | 17M | 18M | 18M | 6M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $68M | $60M | $65M | $54M | $51M | $41M | $45M | $40M |
| Gross Profit | $48M | $42M | $46M | $38M | $35M | $28M | $30M | $26M |
| Gross Margin % | 70.6% | 70.7% | 70.5% | 70.1% | 68.8% | 67.2% | 68.5% | 63.9% |
| Operating Income (EBIT) | ($4M) | ($7M) | ($4M) | ($4M) | ($14M) | ($17M) | ($19M) | ($13M) |
| Operating Margin % | -6.3% | -10.9% | -6.1% | -7.5% | -27.5% | -41.0% | -41.9% | -32.7% |
| Net Income | ($12M) | ($13M) | ($3M) | ($11M) | ($17M) | ($21M) | ($35M) | ($17M) |
| Net Margin % | -17.4% | -22.4% | -4.0% | -20.7% | -32.4% | -50.0% | -77.6% | -41.5% |
| EBITDA | $1M | ($3M) | ($2M) | ($2M) | ($7M) | ($11M) | ($28M) | ($9M) |
| Earnings Per Share (EPS) | $-0.39 | $-0.45 | $-0.09 | $-0.38 | $-0.56 | $-0.70 | $-1.19 | $-0.60 |
| Shares Outstanding (M) | 30M | 30M | 30M | 30M | 29M | 29M | 29M | 28M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($33M) | ($51M) | ($59M) | ($89M) | ($52M) | ($28M) | ($13M) | ($30M) | ($34M) | ($32M) | ($14M) |
| Capital Expenditures (CapEx) | $9M | $7M | $16M | $25M | $34M | $7M | $4M | $7M | $2M | $1M | $11M |
| Free Cash Flow (FCF) | ($42M) | ($58M) | ($74M) | ($113M) | ($86M) | ($34M) | ($16M) | ($37M) | ($36M) | ($33M) | ($25M) |
| FCF Margin % | -17.1% | -27.3% | -44.6% | -68.5% | -53.4% | -27.0% | -19.4% | -41.3% | -58.3% | -94.9% | -125.4% |
| Dividends Paid | — | — | — | — | $4M | $4M | $0M | $2M | — | $36M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($17M) | ($4M) | ($1M) | ($11M) | ($19M) | ($21M) | ($21M) | ($12M) |
| Capital Expenditures (CapEx) | $4M | $2M | $2M | $2M | $2M | $1M | $2M | $2M |
| Free Cash Flow (FCF) | ($20M) | ($6M) | ($2M) | ($13M) | ($20M) | ($21M) | ($23M) | ($14M) |
| FCF Margin % | -29.8% | -10.5% | -3.8% | -24.6% | -39.6% | -51.9% | -50.6% | -35.0% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $352M | $357M | $347M | $269M | $211M | $140M | $156M | $117M | $117M | $57M | $30M |
| Cash & Cash Equivalents | $71M | $76M | $90M | $40M | $66M | $53M | $85M | $38M | $53M | $11M | $0M |
| Total Liabilities | $330M | $334M | $294M | $250M | $219M | $89M | $81M | $77M | $47M | $62M | $56M |
| Total Debt (Short + Long-Term) | $262M | $262M | $221M | $190M | $176M | $52M | $51M | $48M | $28M | $25M | $40M |
| Total Shareholders' Equity | $22M | $24M | $53M | $18M | ($8M) | $51M | $75M | $40M | $69M | ($5M) | ($26M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ESTA viewer.
About TickerBase · Data methodology & sources · Privacy · Terms